Related Experiment Videos
Sequence-dependent nucleotide dynamics revealed by intercalated ring rotation in DNA-bisnaphthalimide complexes
1MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK. Jose.Gallego@medivir.com
Nucleic Acids Research
|July 9, 2004
Summary
Bisnaphthalimide anticancer drugs exhibit 180-degree ring rotations within DNA. These motions, detected by NMR spectroscopy, are sequence-dependent and occur on the millisecond timescale, influencing drug-DNA interactions.
Area of Science:
- Medicinal Chemistry
- Structural Biology
- Biophysics
Background:
- Bisnaphthalimide intercalators are a class of anti-tumour agents featuring two planar rings linked by a flexible chain.
- These compounds function by intercalating into DNA, suggesting their mechanism of action involves interactions with the DNA duplex.
Purpose of the Study:
- To investigate the dynamic behavior of bisnaphthalimide analogues when complexed with DNA.
- To elucidate the relationship between bisnaphthalimide ring motions, DNA nucleotide dynamics, and drug-DNA binding kinetics.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy was employed to detect and analyze the rotational motions of bisnaphthalimide rings within DNA complexes.
- Comparative analysis of rotation frequencies and activation energies under varying conditions and DNA sequences.
Main Results:
- Bisnaphthalimide intercalator rings undergo 180-degree rotational motions within the DNA duplex, independent of the linker atoms.
- These motions were observed across diverse DNA sequences and lengths, occurring on the millisecond timescale.
- Rotation frequencies varied from 2 to 25 s(-1) at 25°C, influenced by DNA composition and ring size.
Conclusions:
- The observed ring rotations are intrinsic properties of the drug-DNA complex, driven by concerted, sequence-dependent nucleotide movements.
- These dynamics are not linked to drug dissociation and may occur within the DNA duplex.
- The identified nucleotide dynamics are crucial for understanding the binding kinetics of DNA-interacting proteins and drugs.